Search

Treating MS in 2025: Practical Issues and Special Considerations Organized by the VA MSCoE

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE This session will address common challenges in the pharmacological management of neuroimmunological conditions. The discussion will begin with special populations, including pregnant and lactating women and older adults. These life stages are characterized by the potential for spontaneous remission of …

MS Update 2026

2026 Charlotte, NC sessions AAPA, ACPE, APA, ASWB, CME, Letter of Completion, NCPD, IPCE This symposium will provide updates on current topics of interest in the MS community. Each topic will be presented with ample time for questions/discussion. Level of Information: Basic, Intermediate, Advanced Patricia K. Coyle , MD

Psychosocial Well-Being Across the MS Lifespan: From Adolescence to Older Adulthood Part 1: The Psychosocial Impact of MS in Adolescents: Providing Supportive Care Part 2: Mental Health and Aging with MS: Every Provider Plays a Role

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Part 1: Pediatric Onset MS patients are more likely to have higher disease activity and may experience two to three times as many clinical attacks as adults. The onset of MS during a developmental period in which myelination is …

Bugs and Drugs: Practical Management Considerations Around Infections and MS Disease Modifying Therapies

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …

Emerging Cell-based Therapies in Multiple Sclerosis

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Nature continues to show that our own body can produce cells that can modify and treat a variety of conditions, including autoimmune diseases like MS. Technology allows for the isolation, purification and modification of cells to exploit their various properties. In this session …

Responding to the Needs of Individuals with Advanced MS: Integrated Approaches to Care, Function, and Quality of Life

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE People living with advanced multiple sclerosis (MS) experience increasing disability, complex symptom burden, and heightened risk of fragmentation or disengagement from care at a time when coordinated support is essential. With the field’s emphasis on disease modification and disability …

The June Halper Memorial Lecture: The Journey is the Destination: 40 Years of CMSC, 40 Years of MS Neuropsychiatry

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …

Spinal Cord in MS: Key Clinical and Imaging Considerations

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Spinal cord disease is important in most people with MS , but is less emphasized in patient care, basic, clinical research, and therapeutic trials. Clinically relevant spinal cord disease in MS is crucial to recognize. How and when to image the spinal cord …

Era of Too Many Choices; Starting and Switching

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE There has been an explosion of new MS disease modifying therapies over the last decade. These therapies offer people with MS many treatment options including different routes of administration and mechanisms of action. With so many treatment options, selecting the right therapy for …